Search Results - "Schouten, Jeoffrey N. L."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Idiopathic noncirrhotic portal hypertension by Schouten, Jeoffrey N.L., Garcia‐Pagan, Juan C., Valla, Dominique C., Janssen, Harry L.A.

    Published in Hepatology (Baltimore, Md.) (02-09-2011)
    “…Idiopathic noncirrhotic portal hypertension (INCPH) is characterized by an increased portal venous pressure gradient in the absence of a known cause of liver…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study by Koehler, Edith M, Schouten, Jeoffrey N.L, Hansen, Bettina E, van Rooij, Frank J.A, Hofman, Albert, Stricker, Bruno H, Janssen, Harry L.A

    Published in Journal of hepatology (01-12-2012)
    “…Background & Aims The prevalence of non-alcoholic fatty liver disease (NAFLD) appears to increase with age. However, limited data are available concerning the…”
    Get full text
    Journal Article
  4. 4

    Idiopathic non-cirrhotic portal hypertension: a review by Schouten, Jeoffrey N L, Verheij, Joanne, Seijo, Susana

    Published in Orphanet journal of rare diseases (30-05-2015)
    “…Idiopathic non-cirrhotic portal hypertension (INCPH) is a rare disease characterized of intrahepatic portal hypertension in the absence of cirrhosis or other…”
    Get full text
    Journal Article
  5. 5

    External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study by Koehler, Edith M, Schouten, Jeoffrey N.L, Hansen, Bettina E, Hofman, Albert, Stricker, Bruno H, Janssen, Harry L.A

    Published in Clinical gastroenterology and hepatology (01-09-2013)
    “…Background & Aims We aimed to validate the fatty liver index (FLI), an algorithm that is based on waist circumference, body mass index, and levels of…”
    Get full text
    Journal Article
  6. 6

    Multiple biopsy passes and the risk of complications of percutaneous liver biopsy by Chi, Heng, Hansen, Bettina E, Tang, Wing Yin, Schouten, Jeoffrey N.L, Sprengers, Dave, Taimr, Pavel, Janssen, Harry L.A, de Knegt, Robert J

    “…BACKGROUND AND AIMTo minimize the sample variability of liver biopsy, the tissue length should be at least 25 mm. Consequently, more than one biopsy pass is…”
    Get full text
    Journal Article
  7. 7

    Role of anticoagulant therapy in liver disease by Plompen, Elisabeth P. C., Schouten, Jeoffrey N. L., Janssen, Harry L. A.

    Published in Hepatology international (01-06-2013)
    “…Anticoagulant therapy is a cornerstone in the treatment of different liver diseases. In Budd-Chiari syndrome (BCS), survival rates have increased considerably…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Serum liver enzymes are associated with all-cause mortality in an elderly population by Koehler, Edith M., Sanna, Donatella, Hansen, Bettina E., van Rooij, Frank J., Heeringa, Jan, Hofman, Albert, Tiemeier, Henning, Stricker, Bruno H., Schouten, Jeoffrey N. L., Janssen, Harry L. A.

    Published in Liver international (01-02-2014)
    “…Background & Aims Little is known about the association of serum liver enzymes with long‐term outcome in the elderly. We sought to clarify the association of…”
    Get full text
    Journal Article
  10. 10

    Histological features in western patients with idiopathic non-cirrhotic portal hypertension by Verheij, Joanne, Schouten, Jeoffrey N L, Komuta, Mina, Nevens, Frederik, Hansen, Bettina E, Janssen, Harry L A, Roskams, Tania

    Published in Histopathology (01-06-2013)
    “…Aims In the western world, idiopathic non‐cirrhotic portal hypertension (INCPH) is a rare disease. This study aimed to investigate the histopathological…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study by van der Voort, Ella A M, Koehler, Edith M, Nijsten, Tamar, Stricker, Bruno H, Hofman, Albert, Janssen, Harry L A, Schouten, Jeoffrey N L, Wakkee, Marlies

    Published in Acta dermato-venereologica (01-02-2016)
    “…Prevalence of non-alcoholic fatty liver disease is increased in patients with psoriasis. However, it is not known how liver fibrosis correlates with psoriasis…”
    Get full text
    Journal Article
  13. 13

    Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals by de Keyser, Catherine E, Koehler, Edith M, Schouten, Jeoffrey N.L, Visser, Loes E, Hofman, Albert, Janssen, Harry L.A, Stricker, Bruno H

    Published in Digestive and liver disease (01-08-2014)
    “…Abstract Background Non-alcoholic fatty liver or hepatic steatosis is considered the hepatic manifestation of the metabolic syndrome. Statins are often used by…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Reversibility of hepatic fibrosis by van der Meer, Adriaan J, Sonneveld, Milan J, Schouten, Jeoffrey N L, Janssen, Harry L A

    “…Although chronic hepatitis has a diverse aetiology, development of hepatic fibrosis is the universal outcome. Cirrhosis is considered to be the universal…”
    Get more information
    Journal Article
  17. 17

    Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding by Schouten, Jeoffrey N L, Verheij, Joanne, Janssen, Harry L A

    “…In three patients, two men aged 57 and 53 years, and a 43-year-old woman, idiopathic portal hypertension, also called non-cirrhotic portal hypertension (NCPH),…”
    Get more information
    Journal Article